Curated Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Curated Wealth Partners's BMY Position: Q2 2026 in Review
Curated Wealth Partners increased its Bristol-Myers Squibb (BMY) stake by 1,367% in Q2 2026, buying an estimated $4.34M and bringing the position to 81,163 shares worth $213K. The position accounts for 0.03% of the portfolio, ranked #498.
Curated Wealth Partners first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $336K in Q1 2026. 953 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Curated Wealth Partners held 81,163 shares of Bristol-Myers Squibb worth $213K as of Q2 2026.
- Curated Wealth Partners bought 75,631 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.34M.
- Bristol-Myers Squibb made up 0.03% of Curated Wealth Partners's portfolio in Q2 2026, its #498 holding.
- Curated Wealth Partners first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Curated Wealth Partners's Bristol-Myers Squibb position peaked at $336K in Q1 2026.
- 953 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Curated Wealth Partners's 13F filing for Q2 2026, filed 13 Jul 2026.